The Orange-III Trial: Optimised Recovery With Movicol® Preoperatively Within an Enhanced Recovery Programme
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aim of this study is to accelerate recovery after liver surgery by enhancing intestinal
passage through the preoperative use of Movicol.
Hypothesis The use of Movicol® during one week prior to partial liver resection combined with
the Enhanced Recovery After Surgery (ERAS®) programme accelerates functional recovery by
promoting early return of gastro-intestinal function, defined as the passage of stools and
early oral intake.